Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

  1. Hernando Cubero, J.
  2. Grande, E.
  3. Jimenez Fonseca, P.
  4. Villabona, C.
  5. Trigo Perez, J.M.
  6. Martinez Trufero, J.
  7. Pajares Bernad, I.
  8. Lopez, C.
  9. Alonso, T.
  10. Biarnes, J.
  11. RamónY Cajal, T.
  12. Duran, M.
  13. Grau, J.J.
  14. Arevalo Lobera, S.
  15. Mesia Nin, R.
  16. Llanos, M.
  17. Dalmau Portulas, E.
  18. Alvarez, C.
  19. Zafon, C.
  20. Capdevila, J.
Zeitschrift:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Datum der Publikation: 2018

Ausgabe: 29

Seiten: viii476

Art: Artikel

DOI: 10.1093/ANNONC/MDY293.022 GOOGLE SCHOLAR lock_openOpen Access editor

Ziele für nachhaltige Entwicklung